Comparison of therapeutic effect of different doses of ganciclovir for neonatal congenital cytomegalovirus infection

HE Xiao-Ri, CHEN Ping-Yang, WANG Tao, XIE Zong-De, HU Jin-Tao, BO Tao, GAI Jian-Fang

Chinese Journal of Contemporary Pediatrics ›› 2009, Vol. 11 ›› Issue (08) : 641-644.

PDF(1024 KB)
PDF(1024 KB)
Chinese Journal of Contemporary Pediatrics ›› 2009, Vol. 11 ›› Issue (08) : 641-644.
CLINICAL RESEARCH

Comparison of therapeutic effect of different doses of ganciclovir for neonatal congenital cytomegalovirus infection

  • HE Xiao-Ri, CHEN Ping-Yang, WANG Tao, XIE Zong-De, HU Jin-Tao, BO Tao, GAI Jian-Fang.
Author information +
History +

Abstract

OBJECTIVE: Ganciclovir is a first-line drug for treatment of cytomegalovirus (CMV) infection. However, some ganciclovir treatment-related side-effects can be found. This study aimed to compare the efficacy and side effects of relatively low and high doses of ganciclovir in the treatment of neonatal congenital CMV infection. METHODS: One hundred and sixty-seven neonates with congenital CMV infection were randomly assigned to high-dose (n=79) and low-dose ganciclovir groups (n=88). The high-dose ganciclovir group was injected with ganciclovir of 7.5 mg/kg in the inducement phase and of 10 mg/kg in the maintaining phase. The low-dose ganciclovir group was injected with ganciclovir of 5 mg/kg in the inducement and the maintaining phases. The efficacy and side effects were observed in the two groups. RESULTS: After treatment the clinical symptoms and signs were obviously improved in both groups. CMV-IgM became negative in 93.8% of neonates in the high-dose ganciclovir group and 93.1% of neonates in the low-dose ganciclovir group (P>0.05). CMV-DNA became negative in 80.8% of neonates in the high-dose ganciclovir group and in 86.7% in the low-dose ganciclovir group (P>0.05). The low-dose ganciclovir group had lower incidence of side effects than the high-dose ganciclovir group: vomiting 2.3% vs 11.4%; anemia 8.0% vs 20.3%; reduction of neutrophilic granulocytes 5.7% vs 16.5%; increase in platelet count 8.0% vs 18.9% (P<0.05).ConclusionsLow-dose ganciclovir has the same clinical efficacy to high-dose ganciclovir for treatment of neonatal congenital CMV infection, but fewer side effects occur in the low-dose group.[Chin J Contemp Pediatr, 2009, 11 (8):641-644]

Key words

Ganciclovir / Dose / Cytomegalovirus / Efficacy / Side effect / Neonate

Cite this article

Download Citations
HE Xiao-Ri, CHEN Ping-Yang, WANG Tao, XIE Zong-De, HU Jin-Tao, BO Tao, GAI Jian-Fang. Comparison of therapeutic effect of different doses of ganciclovir for neonatal congenital cytomegalovirus infection[J]. Chinese Journal of Contemporary Pediatrics. 2009, 11(08): 641-644

References

[1]Centers for Disease Control and Prevention (CDC).Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy-United States, 2007[J].MMWR Morb Mortal Wkly Rep, 2008, 57(3):65-68.
[2]Collinet P, Subtil D, Houfflin-Debarge V, Kacet N, Dewilde A, Puech F. Routine CMV screening during pregnancy[J].Eur J Obstet Gynecol Reprod Biol, 2004, 114(1):3-11.
[3]赵萍,林素惠,郭秀冬,张伟忠.新生儿先天性巨细胞病毒感染15例报告[J].中国当代儿科杂志, 2000, 2(2):101-102.
[4]陈平洋,贺晓日,王涛,邱梅冰,闫淑媛,杨成华,等.新生儿先天性巨细胞病毒感染的临床观察[J].实用儿科杂志,2007,11(22):1697-1698.
[5]张欣文,李芬,史晓薇,于学文,张剑萍,石建.先天性巨细胞病毒感染对无症状患儿生长发育影响[J].第三军医大学学报, 2006, 26(24):2475-2477.
[6]方峰.抗巨细胞病毒药物的研究进展和临床应用[J].临床儿科杂志, 2007, 25(7):528-531.
[7]中华医学会儿科学分会感染消化组.巨细胞病毒感染的诊断方案[J].中华儿科杂志, 1999, 37(7):441-442.
[8]韩丽萍,姜毅,陶源,乔彦霞.婴幼儿巨细胞病毒感染的临床特点及转归[J].实用儿科临床杂志, 2006, 21(7):410-411.
[9]Foweler KB, Boppana SB. Congenital cytomegalovirus(CMV) infection and hearing deficit[J].J Clin Virol, 2006, 35(2):226-231.
[10]董淮富,潘家华,李莉,李兴武.更昔洛韦治疗先天性巨细胞病毒感染疗效观察[J].实用全科医学, 2007, 5(5):396-397.
[11]朱凤莲,李晶,赵军华.更昔洛韦治疗婴儿巨细胞病毒肝炎疗效评估[J].中国误诊学杂志, 2005,1(5):97-98.
[12]黄杰,杨菱芳,吴中匡.更昔洛韦治疗小儿巨细胞病毒性肝炎[J].中国当代儿科杂志,2000,2(3):208-210.
[13]莫樱,沈振宇,陈述枚.更昔洛韦治疗婴儿巨细胞病毒肝炎疗效观察[J].中国当代儿科杂志,2000,2(6):406-407.

PDF(1024 KB)

Accesses

Citation

Detail

Sections
Recommended

/